Literature DB >> 24728044

Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.

Kirsten E Jensen1, Louise T Thomsen1, Sven Schmiedel2, Kirsten Frederiksen2, Bodil Norrild3, Adriaan van den Brule4, Thomas Iftner5, Susanne K Kjær6.   

Abstract

OBJECTIVES: Some studies suggest that Chlamydia trachomatis (CT) enhances cervical carcinogenesis; however, a possible confounding effect of persistent human papillomavirus (HPV) infection was not addressed. We examined the potential role of CT infection in the development of subsequent cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in women with prevalent HPV infection and in a subgroup of women with persistent HPV infection.
METHODS: Participants in this population-based cohort study underwent a structured interview, including history of CT infection, and subsequently cervical exfoliated cells were obtained for HPV DNA and CT DNA testing. Women with high-risk HPV DNA infection and no prevalent cervical disease constituted the overall study population (n=1390). A subgroup of women with persistent HPV infection (n=320) was also identified. All women were passively followed for development of cervical lesions in the national Pathology Data Bank. HRs and 95% CIs for CIN3+ during follow-up (up to 19 years) were estimated in an accelerated failure time model.
RESULTS: Women who reported more than one CT infection had a statistically significantly increased risk of CIN3+ (high-risk HPV-positive, HR=2.51, 95% CI 1.44 to 4.37) (persistent HPV infection, HR=3.65, 95% CI 1.53 to 8.70). We found no association between CT DNA and subsequent risk of CIN3+ among women who were HPV-positive or had a persistent HPV infection at baseline.
CONCLUSIONS: Repeated CT infections increased the risk of CIN3+ among women with prevalent as well as persistent high-risk HPV infection. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cervical Neoplasia; Chlamydia Trachomatis; HPV

Mesh:

Substances:

Year:  2014        PMID: 24728044     DOI: 10.1136/sextrans-2013-051431

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  19 in total

Review 1.  Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Zhaojun Shen; Xiaoli Hu; Luzhe Sun; Xueqiong Zhu
Journal:  Tumour Biol       Date:  2016-03-24

2.  Association Between Common Vaginal Infections and Cervical Non-Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women.

Authors:  Shang-Ying Hu; Sabrina H Tsang; Feng Chen; Qin-Jing Pan; Wen-Hua Zhang; Ying Hong; Joshua N Sampson; Allan Hildesheim; Fang-Hui Zhao; Aimée R Kreimer
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

Review 3.  Association of Genital Infections Other Than Human Papillomavirus with Pre-Invasive and Invasive Cervical Neoplasia.

Authors:  Ishita Ghosh; Ranajit Mandal; Pratip Kundu; Jaydip Biswas
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection.

Authors:  Silva Seraceni; Manola Comar; Francesco De Seta; Claudia Colli; Rossella Del Savio; Giuliano Pesel; Valentina Zanin; Pierlanfranco D'Agaro; Carlo Contini
Journal:  Infect Agent Cancer       Date:  2014-09-08       Impact factor: 2.965

Review 5.  Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health.

Authors:  Sunčanica Ljubin-Sternak; Tomislav Meštrović
Journal:  J Pathog       Date:  2014-12-31

6.  Prevalence of plasmid-bearing and plasmid-free Chlamydia trachomatis infection among women who visited obstetrics and gynecology clinics in Malaysia.

Authors:  Tee Cian Yeow; Won Fen Wong; Negar Shafiei Sabet; Sofiah Sulaiman; Fatemeh Shahhosseini; Grace Min Yi Tan; Elaheh Movahed; Chung Yeng Looi; Esaki M Shankar; Rishien Gupta; Bernard P Arulanandam; Jamiyah Hassan; Sazaly Abu Bakar
Journal:  BMC Microbiol       Date:  2016-03-18       Impact factor: 3.605

Review 7.  Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis.

Authors:  Haiyan Zhu; Zhaojun Shen; Hui Luo; Wenwen Zhang; Xueqiong Zhu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Diversity of Cervical Microbiota in Asymptomatic Chlamydia trachomatis Genital Infection: A Pilot Study.

Authors:  Simone Filardo; Marisa Di Pietro; Maria G Porpora; Nadia Recine; Alessio Farcomeni; Maria A Latino; Rosa Sessa
Journal:  Front Cell Infect Microbiol       Date:  2017-07-14       Impact factor: 5.293

9.  Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining.

Authors:  R Robial; A Longatto-Filho; C M Roteli-Martins; M F Silveira; D Stauffert; G G Ribeiro; I M Linhares; M Tacla; M A Zonta; E C Baracat
Journal:  Infect Agent Cancer       Date:  2017-01-06       Impact factor: 2.965

10.  Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study.

Authors:  Vitaly Smelov; Tarik Gheit; Karin Sundström; Alexander Ploner; Sandrine McKay-Chopin; Carina Eklund; Massimo Tommasino; Joakim Dillner
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.